Company Filing History:
Years Active: 2000-2005
Title: The Innovations of Margaret M Golden-Fleet
Introduction
Margaret M Golden-Fleet is a prominent inventor based in Medford, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies and related proteins. With a total of 3 patents to her name, her work has had a substantial impact on medical research and treatment methodologies.
Latest Patents
Her latest patents include groundbreaking discoveries related to human IL-17F and other CTLA-8-related proteins. One of her notable patents discloses polynucleotides encoding human CTLA-8, now known as IL-17F, along with methods for producing anti-human IL-17F antibodies. Additionally, she has developed methods of treatment utilizing human CTLA-8 proteins, rat CTLA-8 proteins, and herpes CTLA-8 proteins. Another patent focuses on polynucleotides encoding human CTLA-8 related proteins, further advancing the understanding and application of these proteins in therapeutic contexts.
Career Highlights
Margaret has built her career at Genetics Institute, Inc., where she has been instrumental in various research projects. Her innovative approach and dedication to her work have positioned her as a key figure in her field.
Collaborations
Throughout her career, Margaret has collaborated with notable colleagues, including Kenneth A Jacobs and Kerry Kelleher. These partnerships have fostered an environment of innovation and have contributed to the success of her research endeavors.
Conclusion
Margaret M Golden-Fleet's contributions to biotechnology through her patents and research have significantly advanced the field. Her work continues to inspire future innovations in medical treatments and therapies.